Description
Atriopeptin I is an analog of atrial natriuretic peptide (ANP) that exhibits some vasodilatory/hypotensive activities, but is significantly less potent than ANP and other ANP analogs.
Atriopeptin I is an analog of atrial natriuretic peptide (ANP) that exhibits some vasodilatory/hypotensive activities, but is significantly less potent than ANP and other ANP analogs.
| Purity | ≥95% |
|---|---|
| Formula | C83H135N29O30S2 |
| Formula Wt. | 2083.31 |
| Solubility | Soluble in water, acid. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Stewart AG, Thompson JS, Rogers TK, et al. Atrial natriuretic peptide-induced relaxation of pre-constricted isolated rat perfused lungs: a comparison in control and hypoxia-adapted animals. Clin Sci (Lond). 1991 Aug;81(2):201-8. PMID: 1653664.
Numan NA, Gillespie MN, Altiere RJ. Pulmonary vasorelaxant activity of atrial peptides. Pulm Pharmacol. 1990;3(1):29-33. PMID: 1966900.
Synthetic analog of 1,4-naphthoquinone, precurs...
Recombinant HCV antigen fragment.
Endogenous component of sphingolipids; PKC inhi...
Cannabinoid receptor 2 selective agonist.
D-amino acid, incorporated into bacterial cell ...
Quaternary ammonium cationic surfactant, dissoc...
AR antagonist.
Synthetic nitrile compound
Peptide, confers resistance against macrolide a...
FGFR inhibitor.
TxA2 synthase inhibitor.
Amide form of vitamin B3 required for productio...
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Thymidylate synthase inhibitor, potential SHMT,...
Aminoglycoside; protein translation inhibitor, ...
O-GlcNAcase inhibitor.
Mycotoxin produced by Fusarium fungi that infec...
5-HT2A antagonist, potential α1-adrenergic ant...
Endogenous amino acid, also found in meat, dair...
Endogenous sphingosine-based lipid, component o...